eBook: The Ultimate Guide to Clinical Data Management
Ensuring clinical data is ready for regulatory submission This eBook is a must-read that will enable clinical professionals to better…
White papers
White papers
Why do so Many Phase III Fail?
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
THE IMPACT OF COVID-19 ON RANDOMIZED CLINICAL TRIALS
The COVID-19 pandemic has a major impact on the conduct of most on-going clinical trials, in particular on the treatment…
IDDI Comments on FDA Draft Guidance on Expansion Cohorts
The need to consider randomization whenever feasible in expansion cohorts The purpose of IDDI comments on FDA Draft guidance is to…